Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?

AIM: Both dose-escalated external beam radiotherapy (DE-EBRT) and androgen deprivation therapy (ADT) improve outcomes in patients with high-risk prostate cancer. However, there is little evidence specifically evaluating DE-EBRT for patients with high-risk prostate cancer receiving ADT, particularly...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakespeare, Thomas P, Wilcox, Shea W, Aherne, Noel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869660/
https://www.ncbi.nlm.nih.gov/pubmed/27274277
http://dx.doi.org/10.2147/OTT.S105174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869660/
https://www.ncbi.nlm.nih.gov/pubmed/27274277
http://dx.doi.org/10.2147/OTT.S105174

Ejemplares similares